Xylem Inc. (NYSE:XYL) Receives Consensus Rating of “Moderate Buy” from Analysts

Shares of Xylem Inc. (NYSE:XYL) have received a consensus rating of “Moderate Buy” from the fourteen brokerages that are covering the stock, MarketBeat reports. Six equities research analysts have rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average 1-year target price among brokerages that have updated their coverage on the stock in the last year is $153.5385.

A number of brokerages have recently weighed in on XYL. Stifel Nicolaus reduced their price objective on shares of Xylem from $163.00 to $159.00 and set a “buy” rating for the company in a research note on Wednesday, April 29th. JPMorgan Chase & Co. cut their target price on shares of Xylem from $170.00 to $160.00 and set an “overweight” rating for the company in a research note on Thursday, April 16th. UBS Group upped their target price on shares of Xylem from $132.00 to $133.00 and gave the company a “neutral” rating in a research note on Wednesday, April 29th. Barclays cut their target price on shares of Xylem from $156.00 to $154.00 and set an “overweight” rating for the company in a research note on Wednesday, April 29th. Finally, Oppenheimer cut their target price on shares of Xylem from $160.00 to $158.00 and set an “outperform” rating for the company in a research note on Wednesday, April 29th.

Xylem Price Performance

Shares of Xylem stock opened at $116.60 on Tuesday. The firm has a fifty day simple moving average of $113.05 and a 200-day simple moving average of $125.38. The company has a current ratio of 1.46, a quick ratio of 1.10 and a debt-to-equity ratio of 0.13. Xylem has a 1-year low of $105.29 and a 1-year high of $154.27. The stock has a market capitalization of $27.71 billion, a price-to-earnings ratio of 29.00, a PEG ratio of 1.66 and a beta of 1.04.

Xylem (NYSE:XYL) last issued its quarterly earnings data on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share for the quarter, topping analysts’ consensus estimates of $1.09 by $0.03. Xylem had a net margin of 10.79% and a return on equity of 11.26%. The business had revenue of $2.13 billion during the quarter, compared to analysts’ expectations of $2.11 billion. During the same period in the previous year, the company earned $1.03 earnings per share. Xylem’s revenue for the quarter was up 2.7% on a year-over-year basis. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. On average, sell-side analysts expect that Xylem will post 5.51 earnings per share for the current year.

Xylem Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Investors of record on Thursday, May 28th were paid a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a yield of 1.5%. The ex-dividend date was Thursday, May 28th. Xylem’s dividend payout ratio is presently 42.79%.

Insider Buying and Selling at Xylem

In related news, CAO Geri-Michelle Mcshane sold 4,269 shares of the company’s stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $117.46, for a total transaction of $501,436.74. Following the completion of the transaction, the chief accounting officer directly owned 3,605 shares in the company, valued at $423,443.30. This represents a 54.22% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Jerome A. Peribere bought 1,210 shares of the business’s stock in a transaction that occurred on Monday, May 4th. The shares were bought at an average price of $116.61 per share, with a total value of $141,098.10. Following the completion of the purchase, the director owned 27,209 shares in the company, valued at approximately $3,172,841.49. The trade was a 4.65% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. 0.32% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Xylem

Several institutional investors and hedge funds have recently bought and sold shares of XYL. J. Stern & Co. LLP increased its holdings in Xylem by 12,326.6% in the 4th quarter. J. Stern & Co. LLP now owns 45,448,168 shares of the industrial products company’s stock valued at $6,189,132,000 after buying an additional 45,082,435 shares during the period. Norges Bank bought a new stake in Xylem in the 4th quarter valued at $361,012,000. Schroder Investment Management Group increased its holdings in Xylem by 2,055.2% in the 3rd quarter. Schroder Investment Management Group now owns 1,192,682 shares of the industrial products company’s stock valued at $171,687,000 after buying an additional 1,137,342 shares during the period. SEB Asset Management AB bought a new stake in Xylem in the 1st quarter valued at $66,700,000. Finally, Balyasny Asset Management L.P. increased its holdings in Xylem by 346.2% in the 3rd quarter. Balyasny Asset Management L.P. now owns 712,950 shares of the industrial products company’s stock valued at $105,160,000 after buying an additional 553,152 shares during the period. Institutional investors own 87.96% of the company’s stock.

About Xylem

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.